CAS 508-75-8
:Convallatoxin
- (3beta,5beta)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
- (3beta,5beta,17xi)-3-[(6-deoxy-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
- (3beta,5beta,8xi,9xi)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
- (3β,5β)-3-[(6-Deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
- 3-[(6-Deoxyhexopyranosyl)Oxy]-5,14-Dihydroxy-19-Oxocard-20(22)-Enolide
- 3beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-5beta-card-20(22)-enolide
- Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-
- Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)- (9CI)
- Card-20(22)-enolide, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
- Convallaotoxin
- Convallaton
- Convallatoxine
- Convallatoxoside
- Convallotoxin
- Corglycon
- Corglycone
- Corglykon
- Hsdb 3475
- Korglykon
- Mannopyranoside, strophanthidin-3,6-deoxy-, alpha-L-
- Nsc 407808
- Rhamnoside, strophanthidin-3, alpha-L-
- Strophanthidin alpha-L-rhamnoside
- Strophanthidin α-<span class="text-smallcaps">L</span>-rhamnoside
- Strophanthidin, 3-(6-deoxy-alpha-L-mannopyranoside)
- (3β,5β)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
- Convallatoxin
- Card-20(22)-enolide, 3-[(6-deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
- 3BETA,5ALPHA,14-TRIHYDROXY-19-OXO-5BETA,20[22]-CARDENOLIDE-3-[6-DEOXY-ALPHA-L-MANNOPYRANOSYL]
- CONVALLATOXIN(RG)
- 6-deoxy-strophanthidin-alpha-l-mannopyranosid
- 20(22),5BETA-CARDENOLID-19-AL-3BETA,5BETA,14BETA-TRIOL-3BETA-D-[A-1-RHAMNOPYRANOSIDE]
- 0(22)-enolide
- Convallatoxin (=Corglycon)
- STROPHANTHIDIN A-L-RHAMNOPYRANOSIDE
- 3β-[(6-Deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β,14β-card-20(22)-enolide
- STROPHANTHIN 3ALPHA-1-RHAMNOSIDE
- 3β5α14-Trihydroxy-19-oxo-5β20(22)-cardenolide 3-(6-deoxy-α-L-mannopyranoside)
- (5S,10S,13R,14S)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(3,4,5-trihydroxy-6-methyl-2-oxanyl)oxy]-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carboxaldehyde
- CONVALLATOXIN USP/EP/BP
- 3beta-[(6-deoxy-alpha-l-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5beta-card-2
- strophanthidin-3,alpha-l-rhamnosid
- Convapur
- (3beta,5beta)-oxo
- Convalpur
- Strophanthidin α-L-rhamnopyranoside, 3β,5α,14-Trihydroxy-19-oxo-5β,20(22)-cardenolide 3-(6-deoxy-α-L-mannopyranoside)
- 5BETA,20[22]-CARDENOLIDE-19-ONE-3BETA,5ALPHA,14-TRIOL-3-[6-DEOXY-ALPHA-L-MANNOPYRANOSYL]
- 3β-(α-L-Rhamnopyranosyloxy)-5,14-dihydroxy-19-oxo-5β,14β-carda-20(22)-enolide
- 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-5,14-dihydroxy-19-card-20(22)-enolid
- Strophanthidin α-L-rhamnopyranoside
- orglycon
- strophanthidinalpha-l-rhamnoside
- CONVALLATOXIN(P)
- Convallopan
- Weitere Synonyme anzeigen
Convallatoxin
CAS:Convallatoxin is a natural product.Formel:C29H42O10Reinheit:99.27% - 99.53%Farbe und Form:Prisms From Methanol + Ether SolidMolekulargewicht:550.64Convallatoxin
CAS:Natural glycosideFormel:C29H42O10Reinheit:≥ 95.0 % (HPLC)Farbe und Form:PowderMolekulargewicht:550.65Convallatoxin
CAS:Kontrolliertes ProduktApplications Convallatoxin is a cardenolide that is used in the treatment of congestive heart failure. It may also be used in the treatment of tumor cells at nanomolar concentrations due to its anti-proliferative effects; in particular, human lung cancer. It is naturally found in the roots of Adonis Amurensis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Schneider, N., et al.: Nat. Prod. Res., (2015); Yin, L., et al.: Zhong Cao Yao, 45, 3361 (2014);Formel:C29H42O10Farbe und Form:White To Off-WhiteMolekulargewicht:550.64Convallatoxin
CAS:Convallatoxin is a cardiac glycoside, which is derived from the plant Convallaria majalis, commonly known as lily of the valley. This compound operates by specifically inhibiting the Na+/K+-ATPase enzyme, a crucial membrane-bound ion pump that maintains the electrochemical gradients of sodium and potassium ions across the cell membrane. Inhibition of this enzyme leads to an increase in intracellular sodium levels, subsequently affecting calcium ion exchange and resulting in enhanced cardiac contractility.
Formel:C29H42O10Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:550.64 g/mol






